Cipla’s Profit Rises 10% YoY To Rs 801 Cr In Q3
Cipla, an Indian pharmaceutical conglomerate, announced its results for the third quarter ended 31 December, 2022 (Q3FY23) on 25 January. The firm recorded a consolidated profit after tax (PAT) of Rs 801 crore for the quarter, up 10 per cent from the previous year’s figure of Rs 729 crore. In the September 2022 quarter, it […]
